Y-Intercept (HK)’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-20,169
| Closed | -$975K | – | 1943 |
|
|
2025
Q1 | $975K | Buy |
+20,169
| New | +$975K | 0.07% | 416 |
|
|
2024
Q4 | – | Sell |
-5,251
| Closed | -$236K | – | 1562 |
|
|
2024
Q3 | $236K | Sell |
5,251
-42,876
| -89% | -$1.93M | 0.01% | 1099 |
|
|
2024
Q2 | $1.67M | Buy |
48,127
+26,678
| +124% | +$924K | 0.09% | 300 |
|
|
2024
Q1 | $621K | Buy |
+21,449
| New | +$621K | 0.05% | 602 |
|
|
2023
Q1 | – | Sell |
-14,318
| Closed | -$156K | – | 1468 |
|
|
2022
Q4 | $156K | Sell |
14,318
-7,077
| -33% | -$77.2K | 0.02% | 863 |
|
|
2022
Q3 | $180K | Buy |
+21,395
| New | +$180K | 0.02% | 837 |
|